N
NW Dermatology Institute | Portland, OR
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Ritlecitinib
CTP-543
Etrasimod
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 4 total trials
The purpose of the study is to learn about the safety and effects of the study medicine (called ritlecitinib) for the treatment of alopecia areata. A...
Enrolling
Alopecia Areata
Drug: Placebo - 50 mg
Drug: Ritlecitinib 50 mg
The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in a...
Active, not recruiting
Alopecia Areata
Drug: CTP-543
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems